Veno-Occlusive Disease (VOD) Associated with Gemtuzumab Ozogamicin (GO) and Inotuzumab Ozogamicin- Analysis of the FDA Adverse Event Reporting System

May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.709
https://www.valueinhealthjournal.com/article/S1098-3015(18)31009-X/fulltext
Section Title :
Section Order : 41
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31009-X&doi=10.1016/j.jval.2018.04.709
HEOR Topics :
Tags :
Regions :